These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1802582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The use of platelet aggregation inhibitor in nephrodialysis].
    Armani U, Piana A, Griffanti-Bartoli F, Altomonte F.
    Arch Maragliano Patol Clin; 1979; 35(2):63-5. PubMed ID: 400622
    [No Abstract] [Full Text] [Related]

  • 24. Thrombogenicity of dialyzer membranes as assessed by residual blood volume and surface morphology at different heparin dosages.
    Debrand-Passard A, Lajous-Petter A, Schmidt R, Herbst R, von Baeyer H, Krause AA, Schiffl H.
    Contrib Nephrol; 1989; 74():2-9. PubMed ID: 2702140
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S, Korbut R.
    Lancet; 1978 Jun 17; 1(8077):1286-9. PubMed ID: 78050
    [Abstract] [Full Text] [Related]

  • 27. Antithrombotic activity of heparin-ATP complex.
    Obergan TY, Lyapina LA, Pastorova VE.
    Bull Exp Biol Med; 2007 Mar 17; 143(3):299-301. PubMed ID: 18225746
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 17; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 29. Synthesis of a new chemically stable prostacyclin analogue with high and long-lasting activity.
    Iseki K, Kanayama T, Hayasi Y, Shibasaki M.
    Chem Pharm Bull (Tokyo); 1990 Jun 17; 38(6):1769-71. PubMed ID: 2208396
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844).
    Buchanan JO, Fleming JS, Cornish BT, Baryla UM, Gillespie E, Stanton HC, Seiler SM, Keely SL.
    Thromb Res; 1989 Nov 01; 56(3):333-46. PubMed ID: 2559492
    [Abstract] [Full Text] [Related]

  • 34. Leucopenia and hypoxemia during hemodialysis with different membranes: effect of prostacyclin.
    De Broe ME, De Backer WA, Verpooten GA, Vermeire PA, Van Waeleghem JP, Herman AG.
    Contrib Nephrol; 1983 Nov 01; 36():26-30. PubMed ID: 6340951
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A, Will EJ, Davison AM.
    Nephron; 1994 Nov 01; 66(4):431-7. PubMed ID: 8015647
    [Abstract] [Full Text] [Related]

  • 36. [Antithrombotic therapy of ischemic heart disease].
    Liusov VA, Belousov IuB.
    Kardiologiia; 1974 Jul 01; 14(7):113-21. PubMed ID: 4431131
    [No Abstract] [Full Text] [Related]

  • 37. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H, Leschke M.
    Dtsch Med Wochenschr; 2006 Feb 24; 131(8):400-2. PubMed ID: 16479474
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of arterial thrombosis and platelet function by nafazatrom.
    Buchanan MR, Blajchman M, Hirsh J.
    Thromb Res; 1982 Oct 15; 28(2):157-70. PubMed ID: 6758186
    [Abstract] [Full Text] [Related]

  • 39. [Pathological changes in thrombocyte-vascular and coagulative hemostasis under the influence of lead chloride and their correction by using a synthetic analog of prostacyclin].
    Myslyts'kyĭ VF, Podolian SK.
    Fiziol Zh (1994); 1999 Oct 15; 45(4):99-104. PubMed ID: 10474809
    [Abstract] [Full Text] [Related]

  • 40. [Antithrombotic therapy].
    Zahn R.
    Herz; 2014 Nov 15; 39(7):789. PubMed ID: 25336241
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.